Physicians may have a hard time relinquishing their own piece of the healthcare puzzle, whether due to financial incentives or inadequate care coordination, said Heather Zacker, MS, senior director of Care Alliances of Joslin Innovation at Joslin Diabetes Center.
Physicians may have a hard time relinquishing their own piece of the healthcare puzzle, whether due to financial incentives or inadequate care coordination, said Heather Zacker, MS, senior director of Care Alliances of Joslin Innovation at Joslin Diabetes Center.
Transcript (slightly modified)
How do team members work together on one patient without duplicating work or stepping on one another’s toes?
That’s a really interesting question, and I think in a small setting, let’s say a PCP practice or a multispecialty practice, it’s probably easier than in a large health system. So if you have an arena where people are not reimbursed for more, more, more, and there’s respect and ability to work at the top of your license, those are 2 really important features.
But, when you look at it at the system level, again, look across the delivery system and you’ve got the inpatient piece, you’ve got the outpatient piece, you’ve got the patient endocrine practice, you’ve got the primary care piece, you’ve got the community piece, schools, nurses, supermarkets, et cetera.
Without a population health approach that is really driven by payers and by regulators, I think that there’s still incentives for the different providers to be holding onto their piece. Either through the financial incentives that may exist or through the concern for their patients because of lack of knowledge of where are they getting cared for, are they getting the education and support that they need.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More
The Latest in New and Emerging Therapies in Schizophrenia: Dr Megan Ehret
October 22nd 2024In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the future.
Read More